798 related articles for article (PubMed ID: 25884694)
1. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.
Wiggers JK; Groot Koerkamp B; Coelen RJ; Doussot A; van Dieren S; Rauws EA; Schattner MA; van Lienden KP; Brown KT; Besselink MG; van Tienhoven G; Allen PJ; Busch OR; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Verheij J; Jarnagin WR; van Gulik TM
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1156-63. PubMed ID: 26122370
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
[TBL] [Abstract][Full Text] [Related]
4. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
5. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
7. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections.
Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nimura Y; Nagino M
Ann Surg; 2015 Jul; 262(1):121-9. PubMed ID: 25405563
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
9. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
10. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.
Sasaki R; Takeda Y; Funato O; Nitta H; Kawamura H; Uesugi N; Sugai T; Wakabayashi G; Ohkohchi N
World J Surg; 2007 Sep; 31(9):1788-1796. PubMed ID: 17647056
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
[TBL] [Abstract][Full Text] [Related]
12. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
13. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.
Kawarada Y; Isaji S; Taoka H; Tabata M; Das BC; Yokoi H
J Gastrointest Surg; 1999; 3(4):369-73. PubMed ID: 10482688
[TBL] [Abstract][Full Text] [Related]
14. The current management of hilar cholangiocarcinoma.
Jarnagin WR; Fong Y; Blumgart LH
Adv Surg; 1999; 33():345-73. PubMed ID: 10572576
[No Abstract] [Full Text] [Related]
15. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications.
Hasegawa S; Ikai I; Fujii H; Hatano E; Shimahara Y
World J Surg; 2007 Jun; 31(6):1256-63. PubMed ID: 17453285
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.
Matsuda T; Fujita H; Harada N; Kunimoto Y; Tanaka T; Kimura T; Kitaoka H; Asano E; Hosono M; Hayashi T; Ogino K
Am J Clin Oncol; 2013 Oct; 36(5):461-5. PubMed ID: 22706178
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
[TBL] [Abstract][Full Text] [Related]
19. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
Shi QF; Liang TB; Qin YS; Wang WL; Shen Y; Zhang M; Zheng SS
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):622-6. PubMed ID: 18086629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
